1.Pediatric WAGR patient with aniridia-associated glaucoma: A case report.
Patricia Abigail Lim-Tanjutco ; Maria Imelda R. Yap-Veloso
Acta Medica Philippina 2026;60(9):126-132
WAGR syndrome is a rare congenital disorder, occurring in approximately 1 in 500,000 to 1,000,000 individuals, often presenting with ocular malformations such as aniridia. Glaucoma frequently develops when the iris and angle structures are affected, posing a significant risk of vision loss. We report a one-year and seven-month-old patient who presented with corneal opacity of the left eye. Examination revealed corneal opacity, aniridia, and markedly elevated intraocular pressure of 65 mmHg, while the fellow eye, also with aniridia, was normotensive. The patient underwent immediate combined trabeculectomy-trabeculotomy. Postoperative follow-up and timely management of complications allowed acceptable pressure control over one year, though visual prognosis remained guarded. This case highlights the challenges of managing glaucoma in WAGR syndrome, particularly in resource-limited settings. Medical therapy alone is often insufficient, making surgical intervention essential. Combined trabeculectomytrabeculotomy proved effective in maintaining pressure control when glaucoma drainage devices were not feasible. Multiple interventions and close monitoring are frequently required due to the risk of scarring and postoperative complications. Our experience emphasizes the need for a multidisciplinary ophthalmology approach to optimize outcomes. Despite pressure control, visual outcomes often remain poor due to structural anomalies and the challenges inherent to pediatric patients with this rare syndrome.
Human ; World Health Organization ; Wagr Syndrome ; Trabeculectomy ; Resource-limited Settings ; Postoperative Complications ; Patients ; Intraocular Pressure
2.Xen® Gel Stent versus PreserFlo™ MicroShunt as a subconjunctival shunt devices in glaucoma: a systematic review
Muhammad Khoirul Huda ; Astrianda Nadya Suryono
Medical Journal of Indonesia 2026;35(1):27-35
BACKGROUND :
Glaucoma is the leading cause of irreversible blindness and is primarily managed by reducing intraocular pressure (IOP). Minimally invasive glaucoma surgeries, particularly subconjunctival shunt devices such as Xen® Gel Stent and PreserFlo™ MicroShunt, have emerged as alternatives to traditional trabeculectomy. This study aimed to evaluate their effectiveness in lowering IOP, reducing medication use, and assessing reinterventions and safety.
METHODS :
A systematic review was conducted in accordance with Cochrane and PRISMA guidelines. Comprehensive literature searches were conducted across PubMed, Cochrane, EBSCOhost, and Google Scholar databases from the earliest available date to September 2023. Studies comparing Xen® Gel Stent and PreserFlo™ MicroShunt in adult patients with glaucoma were included. Data were extracted on study design, sample size, IOP outcomes, antiglaucoma medication use, reinterventions, and safety outcomes. Quality assessment was performed using the Newcastle-Ottawa Scale.
RESULTS :
Of 5 European studies (2020–2023; 329 patients, 6–18 months of follow-up), 3 studies reported lower postoperative IOP with PreserFlo™ MicroShunt (11.8 [3.7] versus 13.6 [3.5] mmHg, p = 0.02; 10.3 [2.1] versus 14.2 [2.1] mmHg, p = 0.0005; 10.3 [3.2] versus 13.1 [6.4] mmHg, p = 0.019). Only one study noted fewer antiglaucoma medications with PreserFlo™ MicroShunt (0.2 [0.6] versus 1.1 [2.4], p = 0.04). Reinterventions including needling and bleb revisions were higher with Xen® Gel Stent (35.4% versus 11.5%; 20% versus 5%). Complication profiles varied, with hypotony more common in Xen® Gel Stent (6.5% versus 0%), hyphema more common with PreserFlo™ MicroShunt (7.7% versus 3.2%), and stent curling and migration more common with Xen® Gel Stent (15% versus 0%; 2% versus 0%), respectively.
CONCLUSIONS
Both Xen® Gel Stent and PreserFlo™ MicroShunt effectively lowered IOP and reduced medication burden in patients with glaucoma. PreserFlo™ MicroShunt may provide superior IOP control and fewer postoperative interventions. Further prospective studies in diverse populations are warranted.
filtering surgery
;
glaucoma
;
glaucoma drainage implants
;
intraocular pressure
;
minimally invasive surgical procedures
3.A traction suture holding device for glaucoma procedures
Christopher Cyrille N. Cabrera ; Nilo Vincent d G. FlorCruz II
Philippine Journal of Ophthalmology 2022;47(2):111-114
Objective:
We described an adjustable traction technique for glaucoma surgeries that provided
adequate visualization of the surgical field.
Methods:
A prototype device was designed to provide good exposure of the surgical site by using a
peripheral lamellar trans-corneal suture capable of applying and sustaining tension. Adjustments to
the amount of traction required were made through the device.
Results:
The device was used in 9 cases of glaucoma surgeries: 5 trabeculectomies and 4 glaucoma
drainage device implantations. No significant complications were observed.
Conclusions
The device was easy to use and allowed more flexibility for the surgeon.
Glaucoma
;
Trabeculectomy
4.Clinical profile and treatment outcomes of patients with Neovascular Glaucoma in a Tertiary Hospital in the Philippines
Angela Therese Y. Uy ; John Mark S. de Leon ; Jubaida M. Aquino
Philippine Journal of Ophthalmology 2021;46(2):82-87
Objective:
To report the clinical profile and treatment outcomes of neovascular glaucoma (NVG).
Methods:
A retrospective cohort study was done in a single tertiary hospital. Medical records of patients diagnosed
with NVG from January 2000 to August 2018 were reviewed and pertinent data were collected. Study outcomes
included visual acuity (VA) and intraocular pressure (IOP) and were analyzed for eyes that received any of the
following: intravitreal bevacizumab (IVBe), pan-retinal photocoagulation (PRP), trabeculectomy with mitomycin
(trab-MMC), or diode laser cyclophotocoagulation (DLCP) with at least 1 month of follow-up.
Results:
There were 162 patients (181 eyes) diagnosed with NVG. Mean age at the time of diagnosis was 55.6 ± 14
years. Diabetic retinopathy (DR) was observed in 81 (45%) eyes and central retinal vein occlusion (CRVO) in 48
(27%) eyes. Baseline VA was hand movement in 67 (37%) eyes and no light perception (NLP) in 49 (27%) eyes.
Only 60 (33%) eyes had ≥1 month of follow up (mean of 73 ± 119.1 weeks) after procedures were done. IVBe
was done in 22 (37%) eyes, trab-MMC in 20 (33%), PRP in 22 (37%), and DLCP in 24 (40%) eyes. IOP decreased
from 45 to 20 mmHg (p<0.001) but VA decreased from LogMAR 1.7 to 2.1 (p<0.01). There was significant VA
decrease in eyes that underwent a single procedure (p<0.02) but none in eyes that underwent 2 or 3 procedures.
Nonetheless, there was significant IOP decrease (p<0.05) when one procedure was done. Of the 49 eyes that had
baseline sight, 19 (41%) converted to NLP (p<0.01).
Conclusion
Most patients presenting with advanced NVG had DR and CRVO. Procedures led to better IOP
but not VA and some lost vision. Aggressive screening for NVG among high-risk groups is warranted to institute
treatment early.
Bevacizumab
;
Retinal Vein Occlusion
;
Diabetic Retinopathy
;
Glaucoma, Neovascular
;
Trabeculectomy
5.Urrets-Zavalia Syndrome Following Trabeculectomy
Gi Seok PARK ; Yeo Kyoung WON ; Kyoung Nam KIM ; Yeon Hee LEE ; Chang sik KIM
Journal of the Korean Ophthalmological Society 2020;61(2):221-225
PURPOSE: We report a case of Urrets-Zavalia syndrome with a fixed dilated pupil after an uneventful trabeculectomy.CASE SUMMARY: Trabeculectomy was performed on a 51-year-old male who had a history of recurrent uveitis in the left eye, with uncontrolled intraocular pressure despite maximally-tolerated medial therapy. There was no unexpected event during surgery. Topical 1% atropine was used for only 2 days after surgery. In the early postoperative period, 1% prednisolone and 0.3% ofloxacin were given four times a day, then gradually reduced. One month later, only 1% prednisolone was given once a day. Intraocular pressure in his left eye was well controlled from 8–14 mmHg after surgery. One month after surgery, the pupils remained dilated. There was no reaction to topical 2% pilocarpine and no relative afferent pupillary defect or posterior synechia.CONCLUSIONS: Our case, although rare, suggests that Urrets-Zavalia syndrome should be considered in patients with well-controlled intraocular pressure after uneventful trabeculectomy.
Atropine
;
Humans
;
Intraocular Pressure
;
Male
;
Middle Aged
;
Ofloxacin
;
Pilocarpine
;
Postoperative Period
;
Prednisolone
;
Pupil
;
Pupil Disorders
;
Trabeculectomy
;
Uveitis
6.Epstein-Barr Virus-related Corneal Endotheliitis Accompanied with Secondary Glaucoma
Yong Wun CHO ; Hyun Ji KANG ; Gyu Nam KIM ; Hyun A KIM ; In Young CHUNG ; Seong Jae KIM
Journal of the Korean Ophthalmological Society 2020;61(2):205-208
PURPOSE: To report a case of Epstein-Barr virus-related corneal endotheliitis accompanied by secondary glaucoma.CASE SUMMARY: A 73-year-old male presented with blurred vision in his right eye. In the ophthalmic evaluation, there were dispersed keratic precipitates overlying corneal edema. The anterior chamber showed trace ~1+ graded inflammation and an endothelial density decrease. His best-corrected visual acuity and intraocular pressure in the right eye were 0.2 and 34 mmHg, respectively. Paracentesis was performed on the anterior chamber of the right eye to confirm the diagnosis under the suspicion of corneal endotheliitis with trabeculectomy for the intraocular pressure control. Epstein-Barr virus was confirmed using a multiplex polymerase chain reaction (PCR), and oral and eye drops of Acyclovir were used to treat the patient. There was no evidence of a recurrence over 2 years and his intraocular pressure was 12 mmHg and best-corrected visual acuity was maintained at 0.5.CONCLUSIONS: A case of Epstein-Barr virus-related corneal endotheliitis was diagnosed using PCR of the aqueous humor. The patient was treated with an oral antiviral agent and eyedrops without a recurrence.
Acyclovir
;
Aged
;
Anterior Chamber
;
Aqueous Humor
;
Corneal Edema
;
Diagnosis
;
Glaucoma
;
Herpesvirus 4, Human
;
Humans
;
Inflammation
;
Intraocular Pressure
;
Male
;
Multiplex Polymerase Chain Reaction
;
Ophthalmic Solutions
;
Paracentesis
;
Polymerase Chain Reaction
;
Recurrence
;
Trabeculectomy
;
Visual Acuity
7.Comparison of Effects and Complications between Conventional Trabeculectomy and Trabeculectomy with a Collagen Matrix Insertion
Kee Sup PARK ; Kyoung Nam KIM ; Sung Bok LEE ; Jung Yeul KIM ; Chang sik KIM
Journal of the Korean Ophthalmological Society 2018;59(1):50-59
PURPOSE: To compare the surgical outcomes between trabeculectomy with a collagen matrix (Ologen®) insertion and conventional trabeculectomy. METHODS: An ophthalmic examination, including tonometry and a slit lamp examination, was performed 1 week, 2 weeks, 1 month, 2 months, 4 months, 6 months, and 12 months postoperatively in glaucoma patients who underwent a trabeculectomy using Ologen® (experimental group) or a conventional trabeculectomy (control group). Clinical features including success rate and complications were compared between the two groups. RESULTS: In 21 eyes of the experimental group and 42 eyes of the control group, the success rates were 76% and 69%, respectively (p = 0.554). Needling with subconjunctival 5-fluorouracil injection or laser suture lysis of the scleral flap was required in three eyes (14.3%) in the experimental group and 18 eyes (42.9%) in the control group (p = 0.023). The types of complications differed, although the total number of complications did not differ between the two groups (23.8% vs. 19.0%, respectively; p = 0.745). The most common complication in the experimental group was an encapsulated bleb, which occurred in three eyes (14.3%), whereas an avascular bleb occurred in three eyes (7.1%) in the control group. CONCLUSIONS: The success rate of trabeculectomy with Ologen® was comparable to that of conventional trabeculectomy. However, postoperative interventions were less commonly required after trabeculectomy with Ologen®, and the complications differed between the groups. When choosing the surgical method and examining the postoperative condition, these differences should be considered.
Blister
;
Collagen
;
Fluorouracil
;
Glaucoma
;
Humans
;
Manometry
;
Methods
;
Slit Lamp
;
Sutures
;
Trabeculectomy
8.Predictors of Success of Selective Laser Trabeculoplasty Adjusted for Intraocular Pressure Variations
Jun Seok LEE ; Chong Eun LEE ; Sam SEO ; Kyoo Won LEE
Journal of the Korean Ophthalmological Society 2018;59(12):1166-1172
PURPOSE: To investigate the efficacy, and identify predictors of success of selective laser trabeculoplasty (SLT) in open-angle glaucoma (OAG) patients after adjusting for intraocular pressure (IOP) changes in the untreated fellow eye. METHODS: This retrospective chart review included 52 eyes of 52 OAG patients who underwent SLT in one eye and were followed-up for at least 1 year after the procedure. The IOP was measured before the treatment, at 1, 2, and 3 months posttreatment, and every 3 months thereafter. To account for the possible influence of IOP fluctuations on laser outcomes, post-laser IOP values of the treated eye of each patient were also analyzed, after adjusting for IOP changes in the untreated fellow eye. Success was defined as an IOP decrease ≥20% of the pretreatment IOP. The success rate was determined based on Kaplan-Meier survival analysis and factors predictive of success were analyzed using the Cox proportional hazard model. RESULTS: The mean pretreatment IOP was 23.17 ± 6.96 mmHg. The mean IOP reduction was 5.59 ± 4.78 mmHg (29.7%) and the success rate was 65.4% at 1 year. The adjusted mean IOP reduction was 4.70 ± 4.67 mmHg (23.9%) and the adjusted success rate was 53.9%. Pretreatment IOP was associated with SLT success; the higher the pretreatment IOP, the greater the post-laser IOP reduction (p = 0.025). Age and mean deviation index did not show a significant association with SLT success (p = 0.066 and p = 0.464, respectively). CONCLUSIONS: SLT is a safe and effective alternative method of IOP reduction in OAG patients. Herein, pretreatment IOP was the only factor significantly associated with SLT success. IOP fluctuations of the untreated eye should be considered for a better understanding of the impact of treatment.
Glaucoma, Open-Angle
;
Humans
;
Intraocular Pressure
;
Methods
;
Proportional Hazards Models
;
Retrospective Studies
;
Shiga Toxin 1
;
Trabeculectomy
9.Comparison of the Efficacy of Topical Steroids after Trabeculectomy in Patients with Primary Open-angle Glaucoma
Jun Young HA ; Tae Hee LEE ; Mi Sun SUNG ; Sang Woo PARK
Journal of the Korean Ophthalmological Society 2018;59(4):362-368
PURPOSE: To compare the surgical outcomes and intraocular pressure (IOP) reduction after trabeculectomy in patients with primary open-angle glaucoma (POAG) according to treatment with three different postoperative topical steroids. METHODS: A total of 84 eyes of 84 patients who had undergone trabeculectomy for POAG and were followed-up at least 1 year were included in this study. According to the postoperative topical steroid treatment, the patients were divided into three groups involving 0.5% loteprednol etabonate (LE), 1% rimexolone (RMX), and 1% prednisolone acetate (PDA). The mean IOP change, mean number of topical anti-glaucoma medication changes, 1-year success rate, and complication percentage were compared among the three groups. RESULTS: There were significant reductions in the IOP and number of anti-glaucoma medications during the postoperative 1-year follow-up in all of the groups (all, p < 0.05), but there were no differences among the three groups. Postoperative 1-year success rates (68.2% in the LE group, 67.0% in the RMX group, and 65.9% in the PDA group; p = 0.88) and complication percentages of trabeculectomy were not significantly different among the three groups. CONCLUSIONS: There were no statistical differences in the 1-year success rate, complication percentage, visual acuity, IOP, and number of anti-glaucoma medications among treatment regimens. LE and RMX were as effective and safe as PDA after trabeculectomy in patients with POAG.
Follow-Up Studies
;
Glaucoma, Open-Angle
;
Humans
;
Intraocular Pressure
;
Loteprednol Etabonate
;
Prednisolone
;
Steroids
;
Trabeculectomy
;
Visual Acuity
10.A Case of Congenital Glaucoma in Associated with Nail-patella Syndrome
Soomin LEE ; Jong Chul HAN ; Chang Won KEE
Journal of the Korean Ophthalmological Society 2018;59(7):687-690
PURPOSE: To report a case of congenital glaucoma associated with nail-patella syndrome. CASE SUMMARY: A 20-day-old female was referred to our clinic for bilateral intraocular pressure (IOP) elevation and treatment of corneal opacities. Her IOP was 25 mmHg and 30 mmHg in the right and left eyes, respectively. After a diagnosis of congenital glaucoma, bilateral trabeculotomy was performed under general anesthesia. On the first postoperative day, the IOP was 12 mmHg in the right eye and 10 mmHg in the left eye, and remained stable thereafter. The infant was the second of fraternal twins (birth weight of 2.42 kg) and had no family history of any particular disease. During the regular checkup, she was referred to an orthopedic clinic for disorders of the elbow and knee. She presented with a dystrophic thumbnail, patella hypoplasia, elbow hypoplasia, and bilateral triangular protrusions of the lateral iliac crest (iliac horn). Based on the above findings, typical nail-patella syndrome was diagnosed and a mutation in the LMX1B gene was detected. CONCLUSIONS: If glaucoma patients have nail deformities or musculoskeletal abnormalities, nail-patella syndrome should be suspected and a multidisciplinary approach should be conducted.
Anesthesia, General
;
Congenital Abnormalities
;
Corneal Opacity
;
Diagnosis
;
Elbow
;
Female
;
Glaucoma
;
Humans
;
Infant
;
Intraocular Pressure
;
Knee
;
Musculoskeletal Abnormalities
;
Nail-Patella Syndrome
;
Orthopedics
;
Patella
;
Trabeculectomy
;
Twins, Dizygotic


Result Analysis
Print
Save
E-mail